| 1 |
Armellini E, Facciorusso A, Crinò SF. Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis. Medicina (Kaunas) 2023;59. [PMID: 36837560 DOI: 10.3390/medicina59020359] [Reference Citation Analysis]
|
| 2 |
Karaisz FG, Elkelany OO, Davies B, Lozanski G, Krishna SG. A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions. Diagnostics (Basel) 2023;13. [PMID: 36766643 DOI: 10.3390/diagnostics13030536] [Reference Citation Analysis]
|
| 3 |
Lavekar A, Mukewar S. Endobiliary and Pancreatic Radiofrequency Ablations. Journal of Digestive Endoscopy 2022. [DOI: 10.1055/s-0042-1756485] [Reference Citation Analysis]
|
| 4 |
Wadhwa V, Patel N, Grover D, Ali FS, Thosani N. Interventional gastroenterology in oncology. CA Cancer J Clin 2022. [PMID: 36495087 DOI: 10.3322/caac.21766] [Reference Citation Analysis]
|
| 5 |
Farmer W, Hannon G, Ghosh S, Prina-mello A. Thermal ablation in pancreatic cancer: A scoping review of clinical studies. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1066990] [Reference Citation Analysis]
|
| 6 |
Dupré A, Melodelima D, Cilleros C, De Crignis L, Peyrat P, Vincenot J, Rivoire M. High Intensity Focused Ultrasound (HIFU) in Digestive Diseases: An Overview of Clinical Applications for Liver and Pancreatic Tumors. IRBM 2022. [DOI: 10.1016/j.irbm.2022.09.005] [Reference Citation Analysis]
|
| 7 |
D'Onofrio M, Beleù A, Sarno A, De Robertis R, Paiella S, Viviani E, Frigerio I, Girelli R, Salvia R, Bassi C. US-Guided Percutaneous Radiofrequency Ablation of Locally Advanced Pancreatic Adenocarcinoma: A 5-Year High-Volume Center Experience. Ultraschall Med 2022;43:380-6. [PMID: 32797463 DOI: 10.1055/a-1178-0474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Ma Y, Xing Y, Li H, Liang B, Li R, Li J, Li Z, Lin M, Niu L. Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer. J Oncol 2022;2022:3523769. [PMID: 35747123 DOI: 10.1155/2022/3523769] [Reference Citation Analysis]
|
| 9 |
Shuiqing H, Sheng L. Is irreversible electroporation (IRE) an effective and safe ablation method for local advanced pancreatic cancer: A meta-analysis. Health Sciences Review 2022;3:100029. [DOI: 10.1016/j.hsr.2022.100029] [Reference Citation Analysis]
|
| 10 |
Lafond M, Lambin T, Drainville RA, Dupré A, Pioche M, Melodelima D, Lafon C. Pancreatic Ductal Adenocarcinoma: Current and Emerging Therapeutic Uses of Focused Ultrasound. Cancers (Basel) 2022;14:2577. [PMID: 35681557 DOI: 10.3390/cancers14112577] [Reference Citation Analysis]
|
| 11 |
Zhao L, Zhou Y, Bai Z, Zhang F, Yang X. The underlying molecular mechanism of intratumoral radiofrequency hyperthermia-enhanced chemotherapy of pancreatic cancer. Journal of Interventional Medicine 2022;5:57-63. [DOI: 10.1016/j.jimed.2022.02.002] [Reference Citation Analysis]
|
| 12 |
Kerdsirichairat T, Shin EJ. Endoscopic ultrasound guided interventions in the management of pancreatic cancer. World J Gastrointest Endosc 2022; 14(4): 191-204 [DOI: 10.4253/wjge.v14.i4.191] [Reference Citation Analysis]
|
| 13 |
Baust JM, Santucci KL, Van Buskirk RG, Raijman I, Fisher WE, Baust JG, Snyder KK. An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line. Biomedicines 2022;10:450. [DOI: 10.3390/biomedicines10020450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 14 |
D’onofrio M, Olivieri AM, Verrengia F, Moro F, Geraci L, Tomaiuolo L, Longo C, Cicalò F, Cacciatore C, Parisi A, Manfrin E, De Robertis R. Percutaneous Interventional Procedures in Pancreatic Cancer. Imaging and Pathology of Pancreatic Neoplasms 2022. [DOI: 10.1007/978-3-031-09831-4_15] [Reference Citation Analysis]
|
| 15 |
Cilleros C, Dupré A, Chen Y, Vincenot J, Rivoire M, Melodelima D. Intraoperative HIFU Ablation of the Pancreas Using a Toroidal Transducer in a Porcine Model. The First Step towards a Clinical Treatment of Locally Advanced Pancreatic Cancer. Cancers (Basel) 2021;13:6381. [PMID: 34945001 DOI: 10.3390/cancers13246381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Nociarova J, Novak M, Polak J, Hrudka J, Porubsky S, Koc M, Rosina J, Grebenyuk AN, Sery R, Gurlich R, Hajer J. Development of Radiofrequency Ablation Generator and Balloon-Based Catheter for Microendoluminal Thin-Layer Ablation Therapy Using the Rat Duodenum as a Model of Low-Impedance Tissue. J Healthc Eng 2021;2021:9986874. [PMID: 34603652 DOI: 10.1155/2021/9986874] [Reference Citation Analysis]
|
| 17 |
Frigerio I, Paiella S, Barbi E, Bianco R, Boz G, Butturini G, Cantore M, Cardarelli N, Mirko D, Fiorentini G, Giardino A, Lionetto G, Malleo G, Mambrini A, Milella M, Passardi A, Regi P, Salvia R, Scopelliti F, Viviani E, Bassi C, Girelli R. Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial. Pancreatology 2021;21:1342-8. [PMID: 34215498 DOI: 10.1016/j.pan.2021.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 18 |
Bibok A, Kim DW, Malafa M, Kis B. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. World J Gastroenterol 2021; 27(27): 4322-4341 [PMID: 34366607 DOI: 10.3748/wjg.v27.i27.4322] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Iancu I, Bartoș A, Cioltean CL, Breazu C, Iancu C, Bartoș D. Role of radio-ablative technique for optimizing the survival of patients with locally advanced pancreatic adenocarcinoma (Review). Exp Ther Med 2021;22:853. [PMID: 34178126 DOI: 10.3892/etm.2021.10285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Walma MS, Rombouts SJ, Brada LJH, Borel Rinkes IH, Bosscha K, Bruijnen RC, Busch OR, Creemers GJ, Daams F, van Dam RM, van Delden OM, Festen S, Ghorbani P, de Groot DJ, de Groot JWB, Haj Mohammad N, van Hillegersberg R, de Hingh IH, D'Hondt M, Kerver ED, van Leeuwen MS, Liem MS, van Lienden KP, Los M, de Meijer VE, Meijerink MR, Mekenkamp LJ, Nio CY, Oulad Abdennabi I, Pando E, Patijn GA, Polée MB, Pruijt JF, Roeyen G, Ropela JA, Stommel MWJ, de Vos-Geelen J, de Vries JJ, van der Waal EM, Wessels FJ, Wilmink JW, van Santvoort HC, Besselink MG, Molenaar IQ; Dutch Pancreatic Cancer Group. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial. Trials 2021;22:313. [PMID: 33926539 DOI: 10.1186/s13063-021-05248-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Chang KP, Lin SH, Chu YW. Artificial intelligence in gastrointestinal radiology: A review with special focus on recent development of magnetic resonance and computed tomography. Artif Intell Gastroenterol 2021; 2(2): 27-41 [DOI: 10.35712/aig.v2.i2.27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Timmer FEF, Geboers B, Nieuwenhuizen S, Schouten EAC, Dijkstra M, de Vries JJJ, van den Tol MP, de Gruijl TD, Scheffer HJ, Meijerink MR. Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy. Curr Oncol Rep 2021;23:68. [PMID: 33864144 DOI: 10.1007/s11912-021-01057-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Hendricks-Wenger A, Aycock KN, Nagai-Singer MA, Coutermarsh-Ott S, Lorenzo MF, Gannon J, Uh K, Farrell K, Beitel-White N, Brock RM, Simon A, Morrison HA, Tuohy J, Clark-Deener S, Vlaisavljevich E, Davalos RV, Lee K, Allen IC. Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Sci Rep 2021;11:7584. [PMID: 33828203 DOI: 10.1038/s41598-021-87228-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 24 |
Yousaf MN, Ehsan H, Muneeb A, Wahab A, Sana MK, Neupane K, Chaudhary FS. Role of Radiofrequency Ablation in the Management of Unresectable Pancreatic Cancer. Front Med (Lausanne) 2020;7:624997. [PMID: 33644089 DOI: 10.3389/fmed.2020.624997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 25 |
Kwon JH, Chung MJ, Park JY, Lee HS, Hwang HK, Kang CM, Lee WJ, Park MS, Kim N, Bang S, Kim MD. Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population. Acta Radiol 2021;62:164-71. [PMID: 32295390 DOI: 10.1177/0284185120917118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 26 |
Di Matteo FM, Stigliano S. Endoscopic Ultrasound-Guided Therapies for Solid Pancreatic Tumors. Endoscopic Ultrasound Management of Pancreatic Lesions 2021. [DOI: 10.1007/978-3-030-71937-1_14] [Reference Citation Analysis]
|
| 27 |
Lv Z, Sun F, Bian Y, Hao Q, Zhang Y, Xu H, Cai H. Clinical laboratory and imaging diagnosis of pancreatic diseases. Integrative Pancreatic Intervention Therapy 2021. [DOI: 10.1016/b978-0-12-819402-7.00003-6] [Reference Citation Analysis]
|
| 28 |
Zhang H, Zhu X, Zeng Z, Gao X. Interventional therapy combined with radiotherapy for pancreatic carcinoma. Integrative Pancreatic Intervention Therapy 2021. [DOI: 10.1016/b978-0-12-819402-7.00023-1] [Reference Citation Analysis]
|
| 29 |
Merola G, Fusco R, Di Bernardo E, D'Alessio V, Izzo F, Granata V, Contartese D, Cadossi M, Audenino A, Perazzolo Gallo G. Design and Characterization of a Minimally Invasive Bipolar Electrode for Electroporation. Biology (Basel) 2020;9:E303. [PMID: 32967343 DOI: 10.3390/biology9090303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 30 |
Kwon JH, Kim MD, Kim SH, Lee EW, Kahlid SA. Effects of irreversible electroporation on femoral nerves in a rabbit model. Minim Invasive Ther Allied Technol 2020;:1-7. [PMID: 32744129 DOI: 10.1080/13645706.2020.1799820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 31 |
Vanella G, Capurso G, Arcidiacono PG. Endosonography-guided Radiofrequency Ablation in Pancreatic Diseases: Time to Fill the Gap Between Evidence and Enthusiasm. J Clin Gastroenterol 2020;54:591-601. [PMID: 32482951 DOI: 10.1097/MCG.0000000000001370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Wang Y, Wang H, Zhou L, Lu J, Jiang B, Liu C, Guo J. Photodynamic therapy of pancreatic cancer: Where have we come from and where are we going? Photodiagnosis Photodyn Ther 2020;31:101876. [PMID: 32534246 DOI: 10.1016/j.pdpdt.2020.101876] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 33 |
He C, Wang J, Zhang Y, Cai Z, Lin X, Li S. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation. Cancer Med. 2020;9:4699-4710. [PMID: 32410380 DOI: 10.1002/cam4.3119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 34 |
Casadei R, Ricci C, Ingaldi C, Alberici L, Di Marco M, Guido A, Minni F, Serra C. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results—a single-center experience. Updates Surg 2020;72:1089-96. [DOI: 10.1007/s13304-020-00782-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 35 |
Guo X, Zhu H, Zhou K, Jin C, Yang Y, Zhang J, Yang W, Ran L, Dimitrov DD. Effects of high-intensity focused ultrasound treatment on peripancreatic arterial and venous blood vessels in pancreatic cancer. Oncol Lett 2020;19:3839-50. [PMID: 32391096 DOI: 10.3892/ol.2020.11511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 36 |
Testoni SGG, Healey AJ, Dietrich CF, Arcidiacono PG. Systematic review of endoscopy ultrasound-guided thermal ablation treatment for pancreatic cancer. Endosc Ultrasound 2020;9:83-100. [PMID: 32295966 DOI: 10.4103/eus.eus_74_19] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 37 |
Frey GT, Padula CA, Stauffer JA, Toskich BB. Intraoperative Irreversible Electroporation in Locally Advanced Pancreatic Cancer: A Guide for the Interventional Radiologist. Semin Intervent Radiol 2019;36:386-91. [PMID: 31798212 DOI: 10.1055/s-0039-1697640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 38 |
Suker M, Nuyttens JJ, Eskens FALM, Haberkorn BCM, Coene PLO, van der Harst E, Bonsing BA, Vahrmeijer AL, Mieog JSD, Jan Swijnenburg R, Roos D, Koerkamp BG, van Eijck CHJ. Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial). EClinicalMedicine 2019;17:100200. [PMID: 31891135 DOI: 10.1016/j.eclinm.2019.10.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 39 |
Oleinikov K, Dancour A, Epshtein J, Benson A, Mazeh H, Tal I, Matalon S, Benbassat CA, Livovsky DM, Goldin E, Gross DJ, Jacob H, Grozinsky-Glasberg S. Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors. J Clin Endocrinol Metab 2019;104:2637-47. [PMID: 31102458 DOI: 10.1210/jc.2019-00282] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 40 |
Fegrachi S, Walma MS, de Vries JJJ, van Santvoort HC, Besselink MG, von Asmuth EG, van Leeuwen MS, Borel Rinkes IH, Bruijnen RC, de Hingh IH, Klaase JM, Molenaar IQ, van Hillegersberg R. Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. Eur J Surg Oncol. 2019;45:2166-2172. [PMID: 31227340 DOI: 10.1016/j.ejso.2019.06.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 41 |
Das SK, Wang JL, Li B, Zhang C, Yang HF. Clinical effectiveness of combined interventional therapy as a salvage modality for unresectable pancreatic carcinoma. Oncol Lett 2019;18:375-85. [PMID: 31289509 DOI: 10.3892/ol.2019.10323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Wu LM, Zhang LL, Chen XH, Zheng SS. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers? Hepatobiliary Pancreat Dis Int 2019;18:117-24. [PMID: 30655073 DOI: 10.1016/j.hbpd.2019.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 43 |
Foulkes R, Ali Asgari M, Curtis A, Hoskins C. Silver-Nanoparticle-Mediated Therapies in the Treatment of Pancreatic Cancer. ACS Appl Nano Mater 2019;2:1758-72. [DOI: 10.1021/acsanm.9b00439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 44 |
Flak RV, Stender MT, Jensen TM, Andersen KL, Henriksen SD, Mortensen PB, Sall M, Thorlacius-Ussing O. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility. Scand J Gastroenterol 2019;54:252-8. [PMID: 30907286 DOI: 10.1080/00365521.2019.1575465] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 45 |
D'Onofrio M, Beleù A, De Robertis R. Ultrasound-guided percutaneous procedures in pancreatic diseases: new techniques and applications. Eur Radiol Exp 2019;3:2. [PMID: 30671676 DOI: 10.1186/s41747-018-0081-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 46 |
Nabi Z, Reddy DN. Endoscopic Palliation for Biliary and Pancreatic Malignancies: Recent Advances. Clin Endosc. 2019;52:226-234. [PMID: 30665289 DOI: 10.5946/ce.2019.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 47 |
Paiella S, De Pastena M, Romeo F, D'onofrio M, Fontana M, Pea A, De Marchi G, Crinò SF, Bassi C, Salvia R. Ablation treatments in unresectable pancreatic cancer. Minerva Chir 2019;74:263-9. [PMID: 30600963 DOI: 10.23736/S0026-4733.18.07881-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 48 |
Guerrero García A, González-huix F, Levy MJ, García de Paredes A, Vázquez-sequeiros E. Ablative therapy in pancreatic cystic lesions. Gastroenterología y Hepatología (English Edition) 2019;42:43-50. [DOI: 10.1016/j.gastre.2019.01.008] [Reference Citation Analysis]
|
| 49 |
Paiella S, De Pastena M, D'Onofrio M, Crinò SF, Pan TL, De Robertis R, Elio G, Martone E, Bassi C, Salvia R. Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation. Transl Gastroenterol Hepatol 2018;3:80. [PMID: 30505967 DOI: 10.21037/tgh.2018.10.05] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 50 |
Holzgang M, Eigl B, Erdem S, Gloor B, Worni M. Irreversible Electroporation in Pancreatic Cancer. Advances in Pancreatic Cancer 2018. [DOI: 10.5772/intechopen.75737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 51 |
Guerrero García A, González-Huix F, Levy MJ, García de Paredes AG, Vázquez-Sequeiros E. Ablative therapy in pancreatic cystic lesions. Gastroenterol Hepatol 2019;42:43-50. [PMID: 30131274 DOI: 10.1016/j.gastrohep.2018.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 52 |
Di Matteo FM, Saccomandi P, Martino M, Pandolfi M, Pizzicannella M, Balassone V, Schena E, Pacella CM, Silvestri S, Costamagna G. Feasibility of EUS-guided Nd:YAG laser ablation of unresectable pancreatic adenocarcinoma. Gastrointest Endosc 2018;88:168-174.e1. [PMID: 29452076 DOI: 10.1016/j.gie.2018.02.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 53 |
Paik WH, Lee SH, Jang S. Future Perspectives on Endoscopic Ultrasonography-Guided Therapy for Pancreatic Neoplasm. Clin Endosc 2018;51:229-34. [PMID: 29774696 DOI: 10.5946/ce.2018.063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 54 |
Scopelliti F, Pea A, Conigliaro R, Butturini G, Frigerio I, Regi P, Giardino A, Bertani H, Paini M, Pederzoli P, Girelli R. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer. Surg Endosc 2018;32:4022-8. [PMID: 29766302 DOI: 10.1007/s00464-018-6217-x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 31] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 55 |
Tian G, Liu X, Zhao Q, Xu D, Jiang T. Irreversible Electroporation in Patients with Pancreatic Cancer: How Important Is the New Weapon? Biomed Res Int 2018;2018:5193067. [PMID: 29854763 DOI: 10.1155/2018/5193067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 56 |
Ierardi AM, Biondetti P, Coppola A, Fumarola EM, Biasina AM, Alessio Angileri S, Carrafiello G. Percutaneous microwave thermosphere ablation of pancreatic tumours. Gland Surg. 2018;7:59-66. [PMID: 29770302 DOI: 10.21037/gs.2017.11.05] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 57 |
Bai Z, Shi Y, Wang J, Qiu L, Monroe EJ, Teng G, Zhang F, Yang X. Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer. Oncotarget 2017;8:3591-9. [PMID: 27690303 DOI: 10.18632/oncotarget.12295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 58 |
Kumar J, Reccia I, Sodergren MH, Kusano T, Zanellato A, Pai M, Spalding D, Zacharoulis D, Habib N. Radiofrequency assisted pancreaticoduodenectomy for palliative surgical resection of locally advanced pancreatic adenocarcinoma. Oncotarget 2018;9:15732-9. [PMID: 29644005 DOI: 10.18632/oncotarget.24596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 59 |
Saccomandi P, Schena E, Diana M, Marescaux J, Costamagna G. Thermal Treatments of Tumors. Biomedical Engineering Challenges 2018. [DOI: 10.1002/9781119296034.ch10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 60 |
Ruarus A, Vroomen L, Puijk R, Scheffer H, Meijerink M. Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies. Cancers (Basel). 2018;10. [PMID: 29320420 DOI: 10.3390/cancers10010016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 61 |
Mizandari M, Kumar J, Pai M, Chikovani T, Azrumelashvili T, Reccia I, Habib N. Interventional radiofrequency ablation: A promising therapeutic modality in the management of malignant biliary and pancreatic duct obstruction. J Cancer 2018;9:629-37. [PMID: 29556320 DOI: 10.7150/jca.23280] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 62 |
Shah R, Ostapoff KT, Kuvshinoff B, Hochwald SN. Ablative Therapies for Locally Advanced Pancreatic Cancer. Pancreas 2018;47:6-11. [PMID: 29232340 DOI: 10.1097/MPA.0000000000000948] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 63 |
Vogl TJ, Panahi B, Albrecht MH, Naguib NNN, Nour-Eldin NA, Gruber-Rouh T, Thompson ZM, Basten LM. Microwave ablation of pancreatic tumors. Minim Invasive Ther Allied Technol. 2018;27:33-40. [PMID: 29278340 DOI: 10.1080/13645706.2017.1420664] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 64 |
Lakhtakia S. Therapy of Pancreatic Neuroendocrine Tumors: Fine Needle Intervention including Ethanol and Radiofrequency Ablation. Clin Endosc 2017;50:546-51. [PMID: 29207860 DOI: 10.5946/ce.2017.167] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 65 |
Ansari D, Kristoffersson S, Andersson R, Bergenfeldt M. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy. Scand J Gastroenterol 2017;52:1165-71. [PMID: 28687047 DOI: 10.1080/00365521.2017.1346705] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 66 |
Mukewar S, Muthusamy VR. Recent Advances in Therapeutic Endosonography for Cancer Treatment. Gastrointest Endosc Clin N Am 2017;27:657-80. [PMID: 28918804 DOI: 10.1016/j.giec.2017.06.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 67 |
Giardino A, Innamorati G, Ugel S, Perbellini O, Girelli R, Frigerio I, Regi P, Scopelliti F, Butturini G, Paiella S, Bacchion M, Bassi C. Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients. Pancreatology 2017;17:962-6. [PMID: 29037917 DOI: 10.1016/j.pan.2017.09.008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 68 |
Chaudhary S, Sun SY. Endoscopic ultrasound-guided radiofrequency ablation in gastroenterology: New horizons in search. World J Gastroenterol 2017; 23(27): 4892-4896 [PMID: 28785143 DOI: 10.3748/wjg.v23.i27.4892] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 69 |
Granata V, Fusco R, Setola SV, Piccirillo M, Leongito M, Palaia R, Granata F, Lastoria S, Izzo F, Petrillo A. Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. World J Gastroenterol 2017; 23(26): 4767-4778 [PMID: 28765698 DOI: 10.3748/wjg.v23.i26.4767] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 70 |
Lakhtakia S, Seo DW. Endoscopic ultrasonography-guided tumor ablation. Dig Endosc 2017;29:486-94. [PMID: 28171697 DOI: 10.1111/den.12833] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 71 |
Adams MS, Salgaonkar VA, Plata-Camargo J, Jones PD, Pascal-Tenorio A, Chen HY, Bouley DM, Sommer G, Pauly KB, Diederich CJ. Endoluminal ultrasound applicators for MR-guided thermal ablation of pancreatic tumors: Preliminary design and evaluation in a porcine pancreas model. Med Phys 2016;43:4184. [PMID: 27370138 DOI: 10.1118/1.4953632] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 72 |
Paik WH, Seo DW. Echoendoscopic ablative therapy for solid pancreatic tumors. J Dig Dis 2017;18:135-42. [PMID: 28133944 DOI: 10.1111/1751-2980.12453] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Scheffer HJ, Vroomen LGPH, de Jong MC, Melenhorst MCAM, Zonderhuis BM, Daams F, Vogel JA, Besselink MGH, van Kuijk C, Witvliet J, de van der Schueren MAE, de Gruijl TD, Stam AGM, van den Tol PMP, van Delft F, Kazemier G, Meijerink MR. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study. Radiology 2017;282:585-97. [DOI: 10.1148/radiol.2016152835] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 74 |
Dupré A, Melodelima D, Pflieger H, Chen Y, Vincenot J, Kocot A, Langonnet S, Rivoire M. Thermal Ablation of the Pancreas With Intraoperative High-Intensity Focused Ultrasound: Safety and Efficacy in a Porcine Model. Pancreas 2017;46:219-24. [PMID: 27841792 DOI: 10.1097/MPA.0000000000000720] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 75 |
Marsanic P, Mellano A, Sottile A, De Simone M. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma. Med Biol Eng Comput. 2017;55:1123-1127. [PMID: 28078482 DOI: 10.1007/s11517-016-1603-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 76 |
Gouma DJ, Besselink MG. Palliative treatment of pancreatic and periampullary tumors. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set 2017. [DOI: 10.1016/b978-0-323-34062-5.00069-8] [Reference Citation Analysis]
|
| 77 |
Girelli R, Isabella F, Giardino A, Regi P, Scopelliti F, Butturini G. Radiofrequency Ablation of Pancreatic Mass. Diagnosis and Endoscopic Management of Digestive Diseases 2017. [DOI: 10.1007/978-3-319-42358-6_3] [Reference Citation Analysis]
|
| 78 |
Moris M, Atar M, Kadayifci A, Krishna M, Librero A, Richie E, Brugge W, Wallace MB. Thermal ablation of pancreatic cyst with a prototype endoscopic ultrasound capable radiofrequency needle device: A pilot feasibility study. Endosc Ultrasound 2017;6:123-30. [PMID: 28440238 DOI: 10.4103/eus.eus_6_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 79 |
D’Onofrio M, Ciaravino V, De Robertis R, Barbi E, Salvia R, Girelli R, Paiella S, Gasparini C, Cardobi N, Bassi C. Percutaneous ablation of pancreatic cancer. World J Gastroenterol 2016; 22(44): 9661-9673 [PMID: 27956791 DOI: 10.3748/wjg.v22.i44.9661] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 80 |
Huang SY, Wallace MJ. Interventional radiology in the management of hepatopancreatobiliary malignancy and surgical complications. Laparoscopic Liver, Pancreas, and Biliary Surgery 2016. [DOI: 10.1002/9781118781166.ch7] [Reference Citation Analysis]
|
| 81 |
Alvarez-Sánchez MV, Napoléon B. Review of endoscopic radiofrequency in biliopancreatic tumours with emphasis on clinical benefits, controversies and safety. World J Gastroenterol 2016; 22(37): 8257-8270 [PMID: 27729733 DOI: 10.3748/wjg.v22.i37.8257] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 82 |
Linecker M, Pfammatter T, Kambakamba P, DeOliveira ML. Ablation Strategies for Locally Advanced Pancreatic Cancer. Dig Surg 2016;33:351-9. [PMID: 27216160 DOI: 10.1159/000445021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 83 |
D'Onofrio M, Crosara S, De Robertis R, Butturini G, Salvia R, Paiella S, Bassi C, Mucelli RP. Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results. Technol Cancer Res Treat. 2017;16:285-294. [PMID: 27193941 DOI: 10.1177/1533034616649292] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 84 |
Nguyen TH, Park S, Hlaing KK, Kang HW. Temperature feedback-controlled photothermal treatment with diffusing applicator: theoretical and experimental evaluations. Biomed Opt Express 2016;7:1932-47. [PMID: 27231632 DOI: 10.1364/BOE.7.001932] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 85 |
D'Onofrio M, Barbi E, Girelli R, Tinazzi Martini P, De Robertis R, Ciaravino V, Salvia R, Butturini G, Frigerio I, Milazzo T, Crosara S, Paiella S, Pederzoli P, Bassi C. Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma. J Gastrointest Oncol. 2016;7:213-220. [PMID: 27034788 DOI: 10.3978/j.issn.2078-6891.2015.085] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
|
| 86 |
Frigerio I, Girelli R, Giardino A, Regi P, Salvia R, Bassi C. Short term chemotherapy followed by radiofrequency ablation in stage III pancreatic cancer: results from a single center. J Hepatobiliary Pancreat Sci 2013;20:574-7. [PMID: 23591744 DOI: 10.1007/s00534-013-0613-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 87 |
Bimonte S, Leongito M, Granata V, Barbieri A, Del Vecchio V, Falco M, Nasto A, Albino V, Piccirillo M, Palaia R, Amore A, Giacomo Rd, Lastoria S, Setola SV, Fusco R, Petrillo A, Izzo F. Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies. Radiol Oncol 2016;50:14-20. [PMID: 27069445 DOI: 10.1515/raon-2016-0003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 88 |
Paiella S, Salvia R, Ramera M, Girelli R, Frigerio I, Giardino A, Allegrini V, Bassi C. Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review. Gastroenterol Res Pract. 2016;2016:4508376. [PMID: 26981115 DOI: 10.1155/2016/4508376] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 89 |
Song TJ, Seo DW, Lakhtakia S, Reddy N, Oh DW, Park DH, Lee SS, Lee SK, Kim MH. Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc 2016;83:440-3. [PMID: 26344883 DOI: 10.1016/j.gie.2015.08.048] [Cited by in Crossref: 114] [Cited by in F6Publishing: 122] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 90 |
Adams MS, Scott SJ, Salgaonkar VA, Sommer G, Diederich CJ. Thermal therapy of pancreatic tumours using endoluminal ultrasound: Parametric and patient-specific modelling. Int J Hyperthermia 2016;32:97-111. [PMID: 27097663 DOI: 10.3109/02656736.2015.1119892] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 91 |
Martin RCG, O’connor R. The Role of Irreversible Electroporation and Other Ablative Techniques in Patients with Borderline Resectable Pancreatic Cancer. Multimodality Management of Borderline Resectable Pancreatic Cancer 2016. [DOI: 10.1007/978-3-319-22780-1_18] [Reference Citation Analysis]
|
| 92 |
Javed AA, Aziz K, Wolfgang CL. Current Controversies in the Surgical Management of Pancreatic Cancer. Current Controversies in Cancer Care for the Surgeon 2016. [DOI: 10.1007/978-3-319-16205-8_7] [Reference Citation Analysis]
|
| 93 |
Narayanan G. Irreversible Electroporation. Semin Intervent Radiol. 2015;32:349-355. [PMID: 26622097 DOI: 10.1055/s-0035-1564706] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 94 |
Al-Hawary MM, Francis IR, Anderson MA. Pancreatic Solid and Cystic Neoplasms: Diagnostic Evaluation and Intervention. Radiol Clin North Am 2015;53:1037-48. [PMID: 26321452 DOI: 10.1016/j.rcl.2015.05.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 95 |
Takaori K, Bassi C, Biankin A, Brunner TB, Cataldo I, Campbell F, Cunningham D, Falconi M, Frampton AE, Furuse J, Giovannini M, Jackson R, Nakamura A, Nealon W, Neoptolemos JP, Real FX, Scarpa A, Sclafani F, Windsor JA, Yamaguchi K, Wolfgang C, Johnson CD; IAP/EPC study group on the clinical managements of pancreatic cancer. International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. Pancreatology 2016;16:14-27. [PMID: 26699808 DOI: 10.1016/j.pan.2015.10.013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 96 |
Fernandez Ranvier GG, Shouhed D, Inabnet WB 3rd. Minimally Invasive Techniques for Resection of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am 2016;25:195-215. [PMID: 26610782 DOI: 10.1016/j.soc.2015.08.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 97 |
Lu F, Poruk KE, Weiss MJ. Surgery for oligometastasis of pancreatic cancer. Chin J Cancer Res. 2015;27:358-367. [PMID: 26361405 DOI: 10.3978/j.issn.1000-9604.2015.05.02] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
|
| 98 |
Venkat S, Hosein PJ, Narayanan G. Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol. Techniques in Vascular and Interventional Radiology 2015;18:153-8. [DOI: 10.1053/j.tvir.2015.06.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 99 |
Fritz S, Sommer CM, Vollherbst D, Wachter MF, Longerich T, Sachsenmeier M, Knapp J, Radeleff BA, Werner J. Irreversible electroporation of the pancreas is feasible and safe in a porcine survival model. Pancreas 2015;44:791-8. [PMID: 25931252 DOI: 10.1097/MPA.0000000000000331] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 100 |
Gupta R, Reddy DN. Endoscopic stent placement combined with tumor ablation therapy. Gastrointestinal Intervention 2015;4:27-30. [DOI: 10.1016/j.gii.2015.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 101 |
Geranios A, Pikoulis E, Papalois A, Kontos M, Agrogiannis G, Petrou A, Pavlakis E, Felekouras E. Radiofrequency Ablation of the Pancreas: Protective Effect of Local Cooling Techniques. The American Surgeon 2015;81:483-491. [DOI: 10.1177/000313481508100530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 102 |
Elliott JT, Samkoe KS, Gunn JR, Stewart EE, Gardner TB, Tichauer KM, Lee TY, Hoopes PJ, Pereira SP, Hasan T, Pogue BW. Perfusion CT estimates photosensitizer uptake and biodistribution in a rabbit orthotopic pancreatic cancer model: a pilot study. Acad Radiol 2015;22:572-9. [PMID: 25683500 DOI: 10.1016/j.acra.2014.12.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 103 |
Pai M, Habib N, Senturk H, Lakhtakia S, Reddy N, Cicinnati VR, Kaba I, Beckebaum S, Drymousis P, Kahaleh M, Brugge W. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg 2015; 7(4): 52-59 [PMID: 25914783 DOI: 10.4240/wjgs.v7.i4.52] [Cited by in CrossRef: 146] [Cited by in F6Publishing: 163] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 104 |
Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, Izzo F. Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results. Int J Surg. 2015;18:230-236. [PMID: 25917204 DOI: 10.1016/j.ijsu.2015.04.055] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 105 |
Girelli R, Prejanò S, Cataldo I, Corbo V, Martini L, Scarpa A, Claudio B. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation. Radiol Oncol 2015;49:147-54. [PMID: 26029026 DOI: 10.1515/raon-2015-0013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 106 |
Paiella S, Butturini G, Frigerio I, Salvia R, Armatura G, Bacchion M, Fontana M, D'Onofrio M, Martone E, Bassi C. Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study. Dig Surg 2015;32:90-7. [PMID: 25765775 DOI: 10.1159/000375323] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 107 |
Pandya GJ, Shelat VG. Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future. World J Gastrointest Oncol 2015; 7(2): 6-11 [PMID: 25685272 DOI: 10.4251/wjgo.v7.i2.6] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 108 |
Son BK. Management of Borderline Resectable Pancreatic Cancer and Local Treatment of Locally Advanced Pancreatic Cancer. Korean J Pancreas Biliary Tract 2015;20:14-21. [DOI: 10.15279/kpba.2015.20.1.14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 109 |
Rombouts SJ, Vogel JA, van Santvoort HC, van Lienden KP, van Hillegersberg R, Busch OR, Besselink MG, Molenaar IQ. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg. 2015;102:182-193. [PMID: 25524417 DOI: 10.1002/bjs.9716] [Cited by in Crossref: 105] [Cited by in F6Publishing: 119] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 110 |
Rossi S, Viera FT, Ghittoni G, Cobianchi L, Rosa LL, Siciliani L, Bortolotto C, Veronese L, Vercelli A, Gallotti A, Ravetta V. Radiofrequency ablation of pancreatic neuroendocrine tumors: a pilot study of feasibility, efficacy, and safety. Pancreas 2014;43:938-45. [PMID: 24717825 DOI: 10.1097/MPA.0000000000000133] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 111 |
Quesada R, Burdío F, Iglesias M, Dorcaratto D, Cáceres M, Andaluz A, Poves I, Castiella T, Sánchez P, Berjano E, Grande L. Radiofrequency pancreatic ablation and section of the main pancreatic duct does not lead to necrotizing pancreatitis. Pancreas 2014;43:931-7. [PMID: 24977335 DOI: 10.1097/MPA.0000000000000156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 112 |
Fegrachi S, Molenaar I, Klaessens J, Besselink M, Offerhaus J, van Hillegersberg R. Radiofrequency ablation of the pancreas: Two-week follow-up in a porcine model. European Journal of Surgical Oncology (EJSO) 2014;40:1000-7. [DOI: 10.1016/j.ejso.2013.11.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 113 |
Ierardi AM, Lucchina N, Petrillo M, Floridi C, Piacentino F, Bacuzzi A, Fonio P, Fontana F, Fugazzola C, Brunese L, Carrafiello G. Systematic review of minimally invasive ablation treatment for locally advanced pancreatic cancer. Radiol med 2014;119:483-98. [DOI: 10.1007/s11547-014-0417-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 114 |
Carrafiello G, Ierardi AM, Fontana F, Petrillo M, Floridi C, Lucchina N, Cuffari S, Dionigi G, Rotondo A, Fugazzola C. Microwave ablation of pancreatic head cancer: safety and efficacy. J Vasc Interv Radiol. 2013;24:1513-1520. [PMID: 24070507 DOI: 10.1016/j.jvir.2013.07.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 115 |
Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AA, Vieveen JM, Bouwman AR, Meijer S, van Kuijk C, van den Tol PM, Meijerink MR. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol. 2014;25:997-1011; quiz 1011. [PMID: 24656178 DOI: 10.1016/j.jvir.2014.01.028] [Cited by in Crossref: 276] [Cited by in F6Publishing: 290] [Article Influence: 30.7] [Reference Citation Analysis]
|
| 116 |
Keane MG, Bramis K, Pereira SP, Fusai GK. Systematic review of novel ablative methods in locally advanced pancreatic cancer. World J Gastroenterol 2014; 20(9): 2267-2278 [PMID: 24605026 DOI: 10.3748/wjg.v20.i9.2267] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 97] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 117 |
Fegrachi S, Besselink MG, van Santvoort HC, van Hillegersberg R, Molenaar IQ. Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review. HPB (Oxford) 2014;16:119-23. [PMID: 23600801 DOI: 10.1111/hpb.12097] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 118 |
Webb JA, Bardhan R. Emerging advances in nanomedicine with engineered gold nanostructures. Nanoscale 2014;6:2502-30. [PMID: 24445488 DOI: 10.1039/c3nr05112a] [Cited by in Crossref: 220] [Cited by in F6Publishing: 229] [Article Influence: 24.4] [Reference Citation Analysis]
|
| 119 |
Cieslak KP, van Santvoort HC, Vleggaar FP, van Leeuwen MS, ten Kate FJ, Besselink MG, Molenaar IQ. The role of routine preoperative EUS when performed after contrast enhanced CT in the diagnostic work-up in patients suspected of pancreatic or periampullary cancer. Pancreatology 2014;14:125-30. [PMID: 24650967 DOI: 10.1016/j.pan.2014.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 120 |
Wirsching A, Lesurtel M, Clavien P. Pancreas. Palliative Surgery 2014. [DOI: 10.1007/978-3-642-53709-7_12] [Reference Citation Analysis]
|
| 121 |
Rossi M, Orgera G, Hatzidakis A, Krokidis M. Minimally invasive ablation treatment for locally advanced pancreatic adenocarcinoma. Cardiovasc Intervent Radiol 2014;37:586-91. [PMID: 23989503 DOI: 10.1007/s00270-013-0724-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 122 |
Brown DB, Narayanan G. Interventional radiology and the pancreatic cancer patient. Cancer J 2012;18:591-601. [PMID: 23187847 DOI: 10.1097/PPO.0b013e3182745bee] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 123 |
Giardino A, Girelli R, Frigerio I, Regi P, Cantore M, Alessandra A, Lusenti A, Salvia R, Bassi C, Pederzoli P. Triple approach strategy for patients with locally advanced pancreatic carcinoma. HPB (Oxford) 2013;15:623-7. [PMID: 23458679 DOI: 10.1111/hpb.12027] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 124 |
Narayanan G, Hosein PJ, Arora G, Barbery KJ, Froud T, Livingstone AS, Franceschi D, Rocha Lima CM, Yrizarry J. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol. 2012;23:1613-1621. [PMID: 23177107 DOI: 10.1016/j.jvir.2012.09.012] [Cited by in Crossref: 151] [Cited by in F6Publishing: 172] [Article Influence: 15.1] [Reference Citation Analysis]
|
| 125 |
Fegrachi S, Molenaar IQ, Klaessens JH, Besselink MG, Offerhaus JA, van Hillegersberg R. Radiofrequency ablation of the pancreas with and without intraluminal duodenal cooling in a porcine model. J Surg Res. 2013;184:867-872. [PMID: 23726235 DOI: 10.1016/j.jss.2013.04.068] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 126 |
Carrara S, Petrone MC, Testoni PA, Arcidiacono PG. Tumors and new endoscopic ultrasound-guided therapies. World J Gastrointest Endosc 2013; 5(4): 141-147 [PMID: 23596535 DOI: 10.4253/wjge.v5.i4.141] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 127 |
Hlavsa J, Procházka V, Crha M, Svobodová I, Andrašina T, Raušer P, Urbanová L, Pavlík T, Lorenzová J, Nečas A, Kala Z. Healing dynamics of porcine pancreatic parenchyma after radiofrequency ablation - in vivo experimental pilot study. Acta Vet Brno 2012;81:427-31. [DOI: 10.2754/avb201281040427] [Reference Citation Analysis]
|
| 128 |
Clasen S, Pereira PL, Lubienski A, Schäfer A, Mahnken AH, Helmberger T, Mack MG, Eichler K, Vogl TJ, Rosenberg C, Schiffman SC, Martin RCG, de Baère T, Bruners P, Düx M, Mohnike K, Ricke J, Ditter P, Wilhelm KE, Strunk H, Beck A, Hengst S, Erinjeri JP, Gast T. Interventional Oncology. CT- and MR-Guided Interventions in Radiology 2013. [DOI: 10.1007/978-3-642-33581-5_13] [Reference Citation Analysis]
|
| 129 |
Arcidiacono PG, Carrara S, Reni M, Petrone MC, Cappio S, Balzano G, Boemo C, Cereda S, Nicoletti R, Enderle MD, Neugebauer A, von Renteln D, Eickhoff A, Testoni PA. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc 2012;76:1142-51. [PMID: 23021160 DOI: 10.1016/j.gie.2012.08.006] [Cited by in Crossref: 103] [Cited by in F6Publishing: 120] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 130 |
Kim HJ, Seo DW, Hassanuddin A, Kim SH, Chae HJ, Jang JW, Park DH, Lee SS, Lee SK, Kim MH. EUS-guided radiofrequency ablation of the porcine pancreas. Gastrointest Endosc 2012;76:1039-43. [PMID: 23078928 DOI: 10.1016/j.gie.2012.07.015] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 131 |
Procházka V, Hlavsa J, Andrašina T, Starý K, Můčková K, Kala Z, Válek V. Laparoscopic Radiofrequency Ablation of Functioning Pancreatic Insulinoma: Video Case Report. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2012;22:e312-5. [DOI: 10.1097/sle.0b013e318264b607] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 132 |
Girelli R, Frigerio I, Giardino A, Regi P, Gobbo S, Malleo G, Salvia R, Bassi C. Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma. Langenbecks Arch Surg 2013;398:63-9. [DOI: 10.1007/s00423-012-1011-z] [Cited by in Crossref: 67] [Cited by in F6Publishing: 78] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 133 |
Cantore M, Girelli R, Mambrini A, Frigerio I, Boz G, Salvia R, Giardino A, Orlandi M, Auriemma A, Bassi C. Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. Br J Surg. 2012;99:1083-1088. [PMID: 22648697 DOI: 10.1002/bjs.8789] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 134 |
Bagla S, Papadouris D. Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. J Vasc Interv Radiol. 2012;23:142-145. [PMID: 22221480 DOI: 10.1016/j.jvir.2011.10.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 135 |
José A, Sobrevals L, Ivorra A, Fillat C. Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models. Cancer Letters 2012;317:16-23. [DOI: 10.1016/j.canlet.2011.11.004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 136 |
Ikuta S, Kurimoto A, Iida H, Aihara T, Takechi M, Kamikonya N, Yamanaka N. Optimal combination of radiofrequency ablation with chemoradiotherapy for locally advanced pancreatic cancer. World J Clin Oncol 2012; 3(1): 12-14 [PMID: 22247824 DOI: 10.5306/wjco.v3.i1.12] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 137 |
D’onofrio M, Barbi E, De Robertis R, Principe F, Gallotti A, Martone E. Intraoperative Ultrasonography of the Pancreas. Ultrasonography of the Pancreas 2012. [DOI: 10.1007/978-88-470-2379-6_5] [Reference Citation Analysis]
|
| 138 |
Ballarin R, Spaggiari M, Cautero N, De Ruvo N, Montalti R, Longo C, Pecchi A, Giacobazzi P, De Marco G, D'Amico G, Gerunda GE, Di Benedetto F. Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol 2011;17:4747-56. [PMID: 22147975 DOI: 10.3748/wjg.v17.i43.4747] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 120] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 139 |
Kubota K. Recent advances and limitations of surgical treatment for pancreatic cancer. World J Clin Oncol 2011; 2(5): 225-228 [PMID: 21611099 DOI: 10.5306/wjco.v2.i5.225] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 140 |
Malleo G, Marchegiani G, Salvia R, Butturini G, Pederzoli P, Bassi C. Pancreaticoduodenectomy for pancreatic cancer: The Verona experience. Surg Today 2011;41:463-70. [DOI: 10.1007/s00595-010-4419-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 141 |
DI Marco M, Macchini M, Vecchiarelli S, Casadei R, Pezzilli R, Fanti S, Zanoni L, Calculli L, Barbieri E, Santini D, DI Cicilia R, Brandi G, Biasco G. Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer: A literature review and report of two cases. Oncol Lett 2011;2:195-200. [PMID: 22866063 DOI: 10.3892/ol.2011.253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 142 |
Pezzilli R, Serra C, Ricci C, Casadei R, Monari F, D'Ambra M, Minni F. Radiofrequency ablation for advanced ductal pancreatic carcinoma: is this approach beneficial for our patients? A systematic review. Pancreas 2011;40:163-5. [PMID: 21160378 DOI: 10.1097/MPA.0b013e3181eab751] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 143 |
Pezzilli R, Fabbri D, Imbrogno A. Does ablation technique utilized in the management of unresectable locally advanced pancreatic adenocarcinoma? Cancers (Basel) 2010;2:2098-9. [PMID: 24310354 DOI: 10.3390/cancers2042098] [Reference Citation Analysis]
|
| 144 |
Spiliotis J. Commentary on pancreatic carcinoma: the role of radiofrequency ablation in advanced disease. Cancers (Basel) 2010;2:2055-7. [PMID: 24310353 DOI: 10.3390/cancers2042055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 145 |
D’Onofrio M, Barbi E, Girelli R, Martone E, Gallotti A, Salvia R, Martini PT, Bassi C, Pederzoli P, Mucelli RP. Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: An overview. World J Gastroenterol 2010; 16(28): 3478-3483 [PMID: 20653055 DOI: 10.3748/wjg.v16.i28.3478] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 146 |
Yalcin S, Oyan B, Bayraktar Y. Current medical treatment of pancreatic neuroendocrine tumors. Hepatogastroenterology. 2007;54:278-284. [PMID: 24281165 DOI: 10.3390/cancers2031419] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|
